We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+2.82%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$231B
AUM Growth
-$701M
Cap. Flow
-$4.96B
Cap. Flow %
-2.15%
Top 10 Hldgs %
13.13%
Holding
8,738
New
866
Increased
3,703
Reduced
3,052
Closed
702

Top Sells

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$514M
2
MDLZ icon
Mondelez International
MDLZ
+$421M
3
COR icon
Cencora
COR
+$225M
4
IVZ icon
Invesco
IVZ
+$212M
5
MON
Monsanto Co
MON
+$205M

Sector Composition

Rank Sector Weight
1 Technology 8.74%
2 Financials 7.28%
3 Healthcare 6.05%
4 Consumer Discretionary 5.36%
5 Energy 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HBIO icon
6226
Harvard Bioscience
HBIO
$27.9M
$36K ﹤0.01%
659
+584
+779% +$29.9K
HURC icon
6227
Hurco Companies Inc
HURC
$142M
$36K ﹤0.01%
796
-910
-53% -$41.8K
IHY icon
6228
VanEck International High Yield Bond ETF
IHY
$43.2M
$36K ﹤0.01%
+1,494
New +$37.2K
ODC icon
6229
Oil-Dri
ODC
$1.4B
$36K ﹤0.01%
+1,714
New +$34.6K
RGNX icon
6230
PUT
Regenxbio
RGNX
$722M
$36K ﹤0.01%
+500
New +$23.9K
RNRG icon
6231
Global X Renewable Energy Producers ETF
RNRG
$26M
$36K ﹤0.01%
1,020
+108
+12% +$3.81K
SFBC
6232
Sound Financial Bancorp
SFBC
$111M
$36K ﹤0.01%
929
+693
+294% +$26.1K
SIGA icon
6233
SIGA Technologies
SIGA
$224M
$36K ﹤0.01%
6,051
+5,861
+3,085% +$38K
STRS icon
6234
Stratus Properties
STRS
$158M
$36K ﹤0.01%
1,198
+451
+60% +$14.1K
EGRX
6235
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$36K ﹤0.01%
479
-47,501
-99% -$2.99M
SCX
6236
DELISTED
The L.S. Starrett Company
SCX
$36K ﹤0.01%
5,658
+1,326
+31% +$8.7K
PRTK
6237
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$36K ﹤0.01%
3,500
+1,560
+80% +$17.7K
HSTO
6238
DELISTED
Histogen Inc. Common Stock
HSTO
$36K ﹤0.01%
42
+5
+14% +$4.15K
ZN
6239
DELISTED
Zion Oil & Gas, Inc.
ZN
$36K ﹤0.01%
9,028
+3,958
+78% +$15.5K
GCAP
6240
DELISTED
Gain Capital Holdings, Inc.
GCAP
$36K ﹤0.01%
4,770
+1,561
+49% +$12.4K
NAP
6241
DELISTED
Navios Maritime Midstream Partrs
NAP
$36K ﹤0.01%
+9,780
New +$38.4K
GSC
6242
DELISTED
GS Connect S&P GSCI Enhanced Commodity Total Return Strategy Index ETN (maturity subject to postpone
GSC
$36K ﹤0.01%
1,331
-807
-38% -$21.3K
AC
6243
DELISTED
Associated Capital Group
AC
$35K ﹤0.01%
946
-572
-38% -$21.5K
ACTG icon
6244
Acacia Research
ACTG
$451M
$35K ﹤0.01%
8,351
+7,787
+1,381% +$29.9K
BBC icon
6245
Virtus Biotech Clinical Trials ETF
BBC
$49.4M
$35K ﹤0.01%
1,070
+251
+31% +$8.25K
BWFG icon
6246
Bankwell Financial Group
BWFG
$533M
$35K ﹤0.01%
+1,083
New +$34.2K
CLM icon
6247
Cornerstone Strategic Value Fund
CLM
$2.22B
$35K ﹤0.01%
2,497
EURL icon
6248
Direxion Daily FTSE Europe Bull 3x ETF
EURL
$55.8M
$35K ﹤0.01%
+1,060
New +$38.5K
FDLO icon
6249
Fidelity Low Volatility Factor ETF
FDLO
$1.46B
$35K ﹤0.01%
1,141
-1,447
-56% -$44.5K
GOEX icon
6250
Global X Gold Explorers ETF NEW
GOEX
$120M
$35K ﹤0.01%
1,559
-520
-25% -$11.8K

Similar funds

UBS Group's Q2 2018 Portfolio in Review

As of Q2 2018, UBS Group held 8,738 positions worth $231B, down 0.3% from $232B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q2 2018 filing shows 866 new, 3,703 increased, 3,052 reduced and 702 closed positions. Its largest new stake was Invesco Ultra Short Duration ETF: 519,362 shares worth $26.1M. The largest sale was NXP Semiconductors, an estimated $514M.

By sector, the portfolio is most concentrated in Technology at 8.7% of assets, up from 8.1% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2018 buy was Invesco Ultra Short Duration ETF: 519,362 shares worth $26.1M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $1.01B increase.
  • UBS Group's biggest Q2 2018 reduction was NXP Semiconductors, cutting an estimated $514M.
  • UBS Group fully exited Monsanto Co in Q2 2018, selling an estimated $205M.
  • UBS Group's ten largest holdings make up 13% of its $231B portfolio in Q2 2018.
  • UBS Group opened 866 new positions and closed 702 in Q2 2018.
  • UBS Group's portfolio value fell 0.3% quarter-over-quarter to $231B.

Based on UBS Group's 13F filing for Q2 2018, filed 14 Aug 2018.